New Research Shows Mpox Can Be Spread Without Symptoms

For those of us navigating the sprawling landscape of Los Angeles—from the vibrant, high-energy corridors of West Hollywood to the artistic enclaves of Silver Lake—the conversation around public health often feels like a series of reactionary pivots. We’ve seen it with everything from smog alerts to the fallout of the 2022 mpox surge. But a recent study published in Nature Communications has just shifted the goalposts again, and for the LGBTQ+ community and high-risk groups in LA, the implications are sobering. The long-held assumption was that mpox was a “visible” threat—that if you didn’t have the telltale rash or sores, you weren’t a vector for transmission. That belief has just been dismantled.

The End of the “Visible Symptom” Safety Net

The research, led by Joseph A. Lewnard, PhD, from the UC Berkeley School of Public Health, didn’t just look at a handful of cases; it analyzed nearly 8,000 men who have sex with men (MSM) receiving routine STI testing at Kaiser Permanente in Los Angeles. The findings are a wake-up call: roughly 1% of these men tested positive for mpox despite being entirely asymptomatic. While 1% might sound negligible in a vacuum, when scaled across a metropolitan population as dense as Los Angeles, it represents a significant “silent” reservoir of the virus.

This explains a frustrating gap that contact tracers have been battling for years. In the past, health officials tried to map outbreaks by tracing the path from one diagnosed patient to another, but they frequently hit dead ends—cases that appeared out of nowhere with no link to a symptomatic person. We now know why. The virus was moving through the community via people who felt perfectly healthy, unknowingly passing the pathogen to partners through close skin-to-skin contact. This fundamentally changes the risk calculus for anyone utilizing dating apps or attending large-scale events in the city.

The JYNNEOS Variable and the Vaccination Gap

The study also brings a critical data point regarding prevention: the JYNNEOS vaccine. The research confirms that the two-dose series reduces the risk of infection by about 50 percent. In a city like LA, where access to healthcare varies wildly between the affluent hills and the underserved pockets of the Eastside, this 50% reduction is a vital lifeline. However, there is a troubling trend emerging. As the immediate panic of the 2022 outbreak faded, vaccination rates began to plummet.

The Centers for Disease Control and Prevention (CDC) continues to recommend the vaccine for those who have had multiple partners, have been diagnosed with other STIs, or frequent commercial sex venues and large festivals—activities that are deeply woven into the social fabric of Los Angeles. The danger here is a false sense of security. If you believe the virus only spreads through visible lesions, you might skip the shot. But as the UC Berkeley data suggests, the risk of severe disease remains high for the unvaccinated, and the window of exposure is much wider than we previously understood. For a deeper dive into preventative measures, you might explore a comprehensive guide on sexual health screenings to understand how to integrate mpox awareness into your routine care.

Navigating the Social and Psychological Fallout

Beyond the clinical data, there is a psychological layer to this discovery. The idea that one could be a carrier without knowing it introduces a new level of anxiety into intimate encounters. In a city where the “scene” is often defined by liberation and exploration, the introduction of an invisible threat can lead to unnecessary stigma or, conversely, a dangerous complacency. We have to move away from the “symptom-checking” culture and toward a “preventative-maintenance” culture.

The role of institutions like the Los Angeles County Department of Public Health is now more critical than ever. They aren’t just fighting a virus; they are fighting the erosion of urgency. When a disease becomes “background noise,” the most vulnerable populations—including those with HIV or other immune system compromises—are the first to suffer. It is no longer enough to tell people to “look for a rash.” We have to emphasize that the only way to truly know your status is through testing and that the only way to significantly lower your risk is through the vaccine series.

the intersection of mpox with other STIs like syphilis and gonorrhea—which are also frequently asymptomatic—creates a perfect storm. If a person is already navigating the complexities of multiple STI treatments, adding a “silent” viral infection to the mix complicates the clinical picture. This is why integrated care, where mpox screening is bundled with standard annual vaccination schedules, is the only sustainable path forward.

The Local Resource Guide: Protecting Yourself in LA

Given my background in geo-journalism and urban health trends, I know that reading a study in Nature Communications is one thing, but taking action in a city of four million people is another. If this research affects your risk profile here in Los Angeles, you shouldn’t just rely on a general practitioner. You need specialists who understand the specific epidemiology of our city.

Here are the three types of local professionals you should prioritize if you are seeking protection or diagnosis:

• LGBTQ+ Affirming Sexual Health Specialists: Don’t just go to any clinic. Look for providers who specialize in queer health and use trauma-informed care. The criteria here should be a clinic that offers “comprehensive panels”—meaning they don’t just test for the “big three” STIs but are proactive about mpox and HPV screenings. They should be well-versed in the latest CDC guidelines for JYNNEOS administration and be able to provide the two-dose series in a judgment-free environment.
• Public Health Navigators: For those who may not have premium insurance or are navigating the complexities of the healthcare system, a public health navigator is essential. Look for individuals affiliated with county-funded health initiatives. Their primary value is their knowledge of “sliding scale” clinics and government grants that provide free vaccinations. They can help you bypass the bureaucracy of large hospital systems to get immediate access to preventative care.
• Medical Dermatologists with Infectious Disease Experience: Because mpox lesions can mimic herpes, syphilis, or even severe acne, a general dermatologist might miss the mark. You need a specialist who specifically treats viral exanthems (skin eruptions caused by viruses). When vetting a dermatologist, ask if they have experience diagnosing mpox in the current outbreak wave. A specialist who is in touch with the LA County Department of Public Health will be much more likely to catch a subtle infection before it spreads.

Ready to find trusted professionals? Browse our complete directory of top-rated mpoxfeatured experts in the Los Angeles area today.